Vimta Labs
Vimta Labs Share Price Chart
Vimta Labs last traded at ₹538.60 (2026-10-13). Over the past month the stock moved -15.6%, three months the stock moved +16.4%, year the stock moved -34.7%. Its closing range over 52 weeks is ₹401.20 – ₹725.25, with the latest close 25.7% below the high.
Closing prices up to 2026-10-13.
About Vimta Labs
Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider[1]
Business Overview:[1] Vimta Labs Limited is a leading Indian contract research and testing company serving pharmaceuticals, biopharmaceuticals, food, medical devices, agrochemicals, consumer products, electronics, infrastructure, power, cement, oil & gas and mining industries. Its services span preclinical research, clinical research, analytical testing, biologics and peptide development, food testing, environmental monitoring, and EMI/EMC testing. The company also operates a National Reference Food Laboratory in Hyderabad and manages the National Food Laboratory at Navi Mumbai under a 25-year PPP contract with FSSAI.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Vimta Labs reported sales of ₹109.00 crore (+11.2%) and net profit of ₹21.00 crore (+10.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 109.00 | 37.00 | 34.00 | 21.00 | 4.71 |
| Mar 2026 | 109.00 | 39.00 | 36.00 | 21.00 | 4.73 |
| Dec 2025 | 99.00 | 34.00 | 35.00 | 18.00 | 3.94 |
| Sep 2025 | 102.00 | 34.00 | 34.00 | 20.00 | 4.47 |
| Jun 2025 | 98.00 | 34.00 | 35.00 | 19.00 | 4.24 |
| Mar 2025 | 94.00 | 33.00 | 35.00 | 18.00 | 4.12 |
| Dec 2024 | 90.00 | 33.00 | 37.00 | 22.00 | 4.84 |
| Sep 2024 | 85.00 | 30.00 | 35.00 | 15.00 | 3.44 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +32.8% | +23.3% | +28.8% | +30.7% | +20.0% | +10.0% | +16.0% | +11.2% |
| Operating profit growth | +76.5% | +43.5% | +26.9% | +30.8% | +13.3% | +3.0% | +18.2% | +8.8% |
| Net profit growth | +150.0% | +144.4% | +50.0% | +58.3% | +33.3% | -18.2% | +16.7% | +10.5% |
| EPS growth | +156.7% | +126.2% | +47.7% | +53.1% | +29.9% | -18.6% | +14.8% | +11.1% |
| OPM % | 35.0% | 37.0% | 35.0% | 35.0% | 34.0% | 35.0% | 36.0% | 34.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Vimta Labs reported sales of ₹407.00 crore (+18.3%) and net profit of ₹78.00 crore (+16.4%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 407.00 | 142.00 | 35.00 | 78.00 | 17.35 |
| Mar 2025 | 344.00 | 122.00 | 35.00 | 67.00 | 15.13 |
| Mar 2024 | 289.00 | 94.00 | 33.00 | 41.00 | 9.26 |
| Mar 2023 | 315.00 | 94.00 | 30.00 | 47.00 | 10.68 |
| Mar 2022 | 276.00 | 80.00 | 29.00 | 41.00 | 9.29 |
| Mar 2021 | 209.00 | 53.00 | 25.00 | 21.00 | 4.81 |
| Mar 2020 | 181.00 | 30.00 | 17.00 | 7.00 | 1.57 |
| Mar 2019 | 213.00 | 58.00 | 27.00 | 25.00 | 5.73 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +16.4% | -15.0% | +15.5% | +32.1% | +14.1% | -8.3% | +19.0% | +18.3% |
| Operating profit growth | +28.9% | -48.3% | +76.7% | +50.9% | +17.5% | +0.0% | +29.8% | +16.4% |
| Net profit growth | +56.3% | -72.0% | +200.0% | +95.2% | +14.6% | -12.8% | +63.4% | +16.4% |
| EPS growth | +54.0% | -72.6% | +206.4% | +93.1% | +15.0% | -13.3% | +63.4% | +14.7% |
| OPM % | 27.0% | 17.0% | 25.0% | 29.0% | 30.0% | 33.0% | 35.0% | 35.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Vimta Labs.
Get Free AI Stock Analysis FREE →Latest News
-
Vimta Labs Ltd Hits Intraday High with 7.19% Surge on 3 June 2026
-
Vimta Labs Board Recommends Re-appointment of Dr. S. P. Vasireddi as Executive Chairman for Five-Year Term - scanx.trade
-
Vimta Labs Board Recommends Re-appointment of Dr. S. P. Vasireddi as Executive Chairman for Five-Year Term - scanx.trade
-
Vimta Labs Makes Available Audio Recording of Q4 FY2025-26 Earnings Call - scanx.trade
Frequently Asked Questions
What is the share price of Vimta Labs today?
Vimta Labs shares were last quoted at ₹538.60 (+0.2% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Vimta Labs?
Vimta Labs has a price-to-earnings (P/E) ratio of 43.56 and a price-to-book (P/B) ratio of 7.80. The industry P/E is 5.78.
What is the 52-week high and low of Vimta Labs?
The 52-week high of Vimta Labs is ₹775.00 and the 52-week low is ₹377.30.
What is the market cap of Vimta Labs?
The market capitalisation of Vimta Labs is about ₹2,677.52 crore.
How did Vimta Labs perform in its latest quarterly results?
In the latest quarter (Jun 2026), Vimta Labs reported sales of ₹109.00 crore (+11.2%) and net profit of ₹21.00 crore (+10.5%), compared with the same quarter last year.
Is Vimta Labs a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Vimta Labs has a 3-year ROE of 18.00%, 3-year profit growth of 19.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Vimta Labs?
Promoters hold about 35.67% of Vimta Labs.
Which sector does Vimta Labs belong to?
Vimta Labs belongs to the Labs & Life Sciences Services sector.
Other Labs & Life Sciences Services stocks
- Syngene International
- Suraksha Diagnostic
- Quest Laboratories
- Gujarat Inject (Kerala)
- Star Imaging & Path Lab
- Modern Diagnostic & Research Centre
- Invicta Diagnostic
- Vineet Laboratories
All Labs & Life Sciences Services stocks · Browse all stocks A–Z